Updated: 24 November 2025

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

24 November 2025

Must Read

The studies were a significant setback for the optimistic view that semaglutide and other GLP-1 drugs could help prevent a number of brain diseases.

Source link

Premier League highlights: Manchester United 0-1 Everton

Bitcoin miners squeezed by record hashrate even as sector stocks jump

- Advertisement -

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

- Advertisement -

Ozempic Drug Fails to Quell Alzheimer’s in Novo Nordisk Trials

LEAVE A REPLY Cancel reply

Zoë Kravitz Just Wore The It Flat-Shoe Trend in London

Jump Trading Quant Yiming Zhang to Get External Deal From Millennium

Here’s Where the National Fight Over Gerrymandered Maps Stands

Bitcoin adoption rebounds in U.S., but consumers still favor gold and stocks

Fake Windows update page found to install password-stealing malware

More Articles Like This

Category

Links

Stay connected

Mail us : thetimes365@thetimes365.com

Newsletter Signup